The Procter & Gamble Company (NYSE:PG) Shares Sold by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. trimmed its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 4.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 137,008 shares of the company’s stock after selling 6,980 shares during the period. First Citizens Bank & Trust Co.’s holdings in Procter & Gamble were worth $23,730,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in PG. Legacy Financial Group LLC acquired a new position in shares of Procter & Gamble in the 1st quarter worth approximately $270,000. Park Avenue Securities LLC lifted its stake in Procter & Gamble by 10.7% during the first quarter. Park Avenue Securities LLC now owns 83,748 shares of the company’s stock worth $13,588,000 after purchasing an additional 8,084 shares in the last quarter. Aprio Wealth Management LLC boosted its position in shares of Procter & Gamble by 12.8% during the first quarter. Aprio Wealth Management LLC now owns 6,027 shares of the company’s stock worth $978,000 after buying an additional 683 shares during the period. Fragasso Group Inc. grew its stake in shares of Procter & Gamble by 1.9% in the first quarter. Fragasso Group Inc. now owns 11,143 shares of the company’s stock valued at $1,808,000 after buying an additional 210 shares in the last quarter. Finally, Triangle Securities Wealth Management raised its holdings in shares of Procter & Gamble by 3.5% in the 1st quarter. Triangle Securities Wealth Management now owns 15,947 shares of the company’s stock valued at $2,587,000 after buying an additional 540 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Shares of PG opened at $171.28 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The stock has a 50 day moving average price of $171.77 and a 200 day moving average price of $167.11. The company has a market capitalization of $404.23 billion, a price-to-earnings ratio of 28.45, a price-to-earnings-growth ratio of 3.74 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same period last year, the firm posted $1.83 EPS. The company’s revenue was down .6% on a year-over-year basis. Research analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. Procter & Gamble’s dividend payout ratio (DPR) is presently 66.94%.

Insider Buying and Selling

In other Procter & Gamble news, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CEO Jon R. Moeller sold 7,007 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares in the company, valued at $46,203,373.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock worth $65,140,718 in the last quarter. 0.18% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

PG has been the subject of a number of research analyst reports. Evercore ISI raised their target price on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. JPMorgan Chase & Co. raised their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Nine research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $176.21.

Check Out Our Latest Report on Procter & Gamble

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.